EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY 4.0

The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment

Yutaka Yamamoto, Chikako Yamauchi, Tatsuya Toyama, Shigenori Nagai, Takehiko Sakai, Goro Kutomi, Michio Yoshimura, Masaaki Kawai, Shoichiro Ohtani, Kazunori Kubota, Kazutaka Nakashima, Naoko Honma und 5 weitere

Breast Cancer · 2024

DOI: 10.1007/s12282-024-01566-6 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Breast Cancer, 2024. Verfasst von Yutaka Yamamoto und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Endocrine Surgery, Kumamoto University Hospital, 1-1-1 Honjo, Chuo-Ku, Kumamoto, 860-8556, Japan. yyamamoto@kumamoto-u.ac.jp. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japanese Breast Cancer Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition was published in June 2022. The guidelines were prepared while conforming as much as possible to the “Minds Manual for Guideline Development 2020 ver. 3.0.” edited by the Minds Manual Development Committee of the Japan Council for Quality Health Care in 2021. In addition, a survey of Japanese Breast Cancer Society members on the 2018 edition of the guidelines was conducted from February 19 to March 4, 2021. Based on the responses from over 600 members, original innovations were made to make the guidelines more user-friendly. The 2018 edition of the guidelines was developed to provide support tools for physicians and patients to utilize shared decision-making. The 2022 guidelines consist of two volumes: (1) an “Epidemiology and Diagnosis” section covering “Screening and Diagnosis”, “Radiological diagnosis”, and “Pathological diagnosis”, and (2) a “Treatment” section covering “Surgical therapy”, “Radiation therapy”, and “Systemic therapy”. We believe that this concise summary of the guidelines will be useful to physicians and researchers in Japan and overseas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHumansFemaleJapanSocieties, MedicalMedical OncologyEast Asian People

Stichwörter der Autor:innen

Breast cancerGuidelineLocal therapySystemic therapy

Autor:innen und Institutionen

  • Department of Breast and Endocrine Surgery, Kumamoto University Hospital, 1-1-1 Honjo, Chuo-Ku, Kumamoto, 860-8556, Japan. yyamamoto@kumamoto-u.ac.jp.
  • Department of Radiation Oncology, Shiga General Hospital, Shiga, Japan.
  • Department of Breast Surgery, Nagoya City University, Aichi, Japan.
  • Division of Breast Oncology, Saitama Cancer Center, Saitama, Japan.
  • Department of Breast Surgical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Department of Surgery, Surgical Oncology and Science, Sapporo Medical University Hospital, Sapporo, Japan.

Förderung

  • Japanese Breast Cancer Society

Zitieren

APA

Yamamoto, Y., Yamauchi, C., Toyama, T., Nagai, S., Sakai, T., Kutomi, G., Yoshimura, M., Kawai, M., Ohtani, S., Kubota, K., Nakashima, K., Honma, N., Yoshida, M., Tokunaga, E., Taira, N., Iwata, H., & Saji, S. (2024). The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment. Breast Cancer. https://doi.org/10.1007/s12282-024-01566-6

Vancouver

Yamamoto Y, Yamauchi C, Toyama T, Nagai S, Sakai T, Kutomi G, et al. The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment. Breast Cancer. 2024. doi:10.1007/s12282-024-01566-6

BibTeX
@article{Yamamoto2024,
  author = {Yamamoto, Yutaka and Yamauchi, Chikako and Toyama, Tatsuya and Nagai, Shigenori and Sakai, Takehiko and Kutomi, Goro and Yoshimura, Michio and Kawai, Masaaki and Ohtani, Shoichiro and Kubota, Kazunori and Nakashima, Kazutaka and Honma, Naoko and Yoshida, Masayuki and Tokunaga, Eriko and Taira, Naruto and Iwata, Hiroji and Saji, Shigehira},
  title = {The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment},
  journal = {Breast Cancer},
  year = {2024},
  doi = {10.1007/s12282-024-01566-6}
}
Kostenlos starten →